FFS
PFE icon

Flavin Financial Services’s Pfizer PFE Stock Holding History

Flavin Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,334
Closed -$663K – 73
2025
Q2 		$663K Buy
27,334
+154
+0.6% +$3.59K 0.64% 45
2025
Q1 		$689K Sell
27,180
-1,005
-4% -$26.3K 0.63% 51
2024
Q4 		$748K Buy
+28,185
New +$765K 0.71% 46

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Flavin Financial Services's PFE Position: Q3 2025 in Review

Flavin Financial Services sold out of Pfizer (PFE) in Q3 2025, closing a stake of 27,334 shares — an estimated $663K sold.

Flavin Financial Services first reported a position in PFE in Q4 2024 and held it in 3 quarters. The position peaked at $748K in Q4 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Flavin Financial Services reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Flavin Financial Services sold 27,334 Pfizer shares in Q3 2025, an estimated $663K.
  • Flavin Financial Services first reported a position in Pfizer in Q4 2024 and held it in 3 quarters.
  • Flavin Financial Services's Pfizer position peaked at $748K in Q4 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Flavin Financial Services's 13F filing for Q3 2025, filed 13 Nov 2025.